価格表

在庫・価格 : 2025年04月27日 05時50分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Glybenclamide <NLRP3 Inhibitor>
データシート
NBP2-30141 NOVノバス バイオロジカルス
Novus biologicals, LLC
1000 mg ¥33,000
(未発注)
追加

在庫・価格 : 2025年04月27日 05時50分 現在

Glybenclamide <NLRP3 Inhibitor>

  • 商品コード:NBP2-30141
  • メーカー:NOV
  • 包装:1000mg
  • 価格: ¥33,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Cho JS et al. Neutrophil-derived IL-1&#x3B2; is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 2012;8(11):e1003047
Cho JS et al
2012/01/01
PubMed
2 Zhang F et al. The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities. Sci Rep 2016;6:24166
Zhang F et al
2016/01/01
PubMed
3 Hsieh CW et al. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease. J. Rheumatol. 2017 08;44(8):1142-1150
Hsieh CW et al
2017/01/01
Species: Human, Applications: InhibAct PubMed
4 Qin L et al. NLRP3 Inflammasome Activation Regulates Aged RBC Clearance. Inflammation 2018 Aug;41(4):1361-1371
Qin L et al
2018/01/01
Species: Human, Applications: InhibAct PubMed
5 Iida T et al. Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation. Cell Mol Gastroenterol Hepatol 2020;9(2):277-293
Iida T et al
2020/01/01
PubMed
6 Phulphagar K et al. Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis. Cell Rep 2021 Mar;34(10):108826
Phulphagar K et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Cho JS et al. Neutrophil-derived IL-1&#x3B2; is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 2012;8(11):e1003047
    Cho JS et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zhang F et al. The caspase-1 inhibitor AC-YVAD-CMK attenuates acute gastric injury in mice: involvement of silencing NLRP3 inflammasome activities. Sci Rep 2016;6:24166
    Zhang F et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Hsieh CW et al. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease. J. Rheumatol. 2017 08;44(8):1142-1150
    Hsieh CW et al
    2017/01/01
  • 備考:
    Species: Human, Applications: InhibAct
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Qin L et al. NLRP3 Inflammasome Activation Regulates Aged RBC Clearance. Inflammation 2018 Aug;41(4):1361-1371
    Qin L et al
    2018/01/01
  • 備考:
    Species: Human, Applications: InhibAct
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Iida T et al. Down-regulation of RalGTPase-Activating Protein Promotes Colitis-Associated Cancer via NLRP3 Inflammasome Activation. Cell Mol Gastroenterol Hepatol 2020;9(2):277-293
    Iida T et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Phulphagar K et al. Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis. Cell Rep 2021 Mar;34(10):108826
    Phulphagar K et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed